Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Irritable Bowel Syndrome, September 2025 Free Subscription Abstracts Retrieve all available abstracts of the following 81 articles: HTML format

Single Articles

1. KARUNANAYAKE A, Rajindrajith S, Kumari MV, Devanarayana NM, et al
   Effects of body mass index on gastric motility: Comparing children with functional abdominal pain disorders and healthy controls.
   World J Clin Pediatr. 2025;14:100306.
   PubMed    
   Abstract available
   
   

2. KHAN U, Bronstad I, Hillestad EMR, Steinsvik EK, et al
   Increase in circulating GLP-1 following low FODMAP diet in irritable bowel syndrome patients.
   Front Nutr. 2025;12:1615671.
   PubMed    
   Abstract available
   
   

3. ALYAMI SH, Lomer MCE, Gibson R
   Gastrointestinal Symptoms and the Assessment of Diet in Shift Workers: A Systematic Scoping Review.
   J Hum Nutr Diet. 2025;38:e70114.
   PubMed    
   Abstract available
   
   

4. ALDERSON SL, Black CJ, Ford AC, Everitt HA, et al
   Management of irritable bowel syndrome in primary care.
   Br J Gen Pract. 2025;75:429-431.
   PubMed    
   
   
   

5. LIU AY, Vera AO, Enos CW
   Irritable Bowel Syndrome Risk in Acne Patients: Implications for Dermatologic Care.
   Cutis. 2025;116:32-35.
   PubMed    
   
   
   

6. MOHAMMED HA, Sulaiman GM, Al-Saffar AZ, Mohsin MH, et al
   Aromatic Volatile Compounds of Essential Oils: Distribution, Chemical Perspective, Biological Activity, and Clinical Applications.
   Food Sci Nutr. 2025;13:e70825.
   PubMed    
   Abstract available
   
   

7. LONG Q, Li L, Deng N, Tan Z, et al
   One mechanism of spleen-kidney yang deficiency IBS-D: intestinal microbiota affect ATPase.
   Front Microbiol. 2025;16:1595418.
   PubMed    
   Abstract available
   
   

8. CHOI WG, Ko SJ, Shim JH, Bae CH, et al
   Integrative In Silico and In Vivo Analysis of Banhasasim-Tang for Irritable Bowel Syndrome: Mechanistic Insights into Inflammation-Related Pathways.
   Pharmaceuticals (Basel). 2025;18:1123.
   PubMed    
   Abstract available
   
   

9. KOVACS E, Szabo K, Varvara RA, Uifalean A, et al
   Resistant Starch and Microbiota-Derived Secondary Metabolites: A Focus on Postbiotic Pathways in Gut Health and Irritable Bowel Syndrome.
   Int J Mol Sci. 2025;26:7753.
   PubMed    
   Abstract available
   
   

10. MAVROUDIS I, Franekova K, Petridis F, Ciobica A, et al
    Comorbidities Across Functional Neurological Disorder Subtypes: A Comprehensive Narrative Synthesis.
    Life (Basel). 2025;15:1322.
    PubMed    
    Abstract available
    
    

11. ALAEDDIN S, Ko Y, Steiner-Lim GZ, Jensen SO, et al
    The Effect of Faecal Microbiota Transplantation on Cognitive Function in Cognitively Healthy Adults with Irritable Bowel Syndrome: Protocol for a Randomised, Placebo-Controlled, Double-Blinded Pilot Study.
    Methods Protoc. 2025;8:83.
    PubMed    
    Abstract available
    
    

12. LANE RM, Egan LJ, McGuire BE, McKernan DP, et al
    Endocannabinoid system modulation for visceral abdominal pain in inflammatory bowel disease and irritable bowel syndrome: A protocol for systematic review and meta-analysis.
    HRB Open Res. 2025;8:40.
    PubMed    
    Abstract available
    
    

13. FANG L, Zhu F, Xie X, Shi Y, et al
    Efficacy and safety analysis of ultrasound endoscopy-guided sclerotherapy of esophagogastric varices: A retrospective study.
    Medicine (Baltimore). 2025;104:e43499.
    PubMed    
    Abstract available
    
    

14. BAYDOUN H, Hussain N, Wu KO, Kelly CR, et al
    What's New and What's Next in Fecal Microbiota Transplantation?
    Biologics. 2025;19:481-496.
    PubMed    
    Abstract available
    
    

15. SAPS M, Arrizabalo S
    Abdominal pain in children: guidelines at last.
    Expert Rev Gastroenterol Hepatol. 2025.
    PubMed    
    
    
    

16. MCCLELLAN N, Ahlawat R, Kambanis PE, Graver H, et al
    Patterns of Symptom Change in Behaviors and Cognitions During 10-Session Cognitive Behavioral Therapy (CBT-T) for Non-Underweight Eating Disorders.
    Int J Eat Disord. 2025;58:1392-1398.
    PubMed    
    Abstract available
    
    

17. YOUSEF A, Ahmed ST, H Nguyen Wenker T, Nono-Djotsa ABS, et al
    Upper gastrointestinal symptoms and Gulf War Illness in a clinical cohort of US veterans: a retrospective, cross-sectional study.
    BMJ Open Gastroenterol. 2025;12:e001859.
    PubMed    
    Abstract available
    
    

18. LUPE SE, Olson JM, Kamp K, Heitkemper M, et al
    First Real-World Evidence of an AI-Enhanced Digital Collaborative Care Model to Improve IBS Symptoms.
    Neurogastroenterol Motil. 2025 Sep 4:e70144. doi: 10.1111/nmo.70144.
    PubMed    
    Abstract available
    
    

19. FAISAL, Sekhar SRM, Anurag DS, Kumar V, et al
    Deciphering Gut Microbiome Dynamics in Irritable Bowel Syndrome Using Deep Learning.
    Neurogastroenterol Motil. 2025 Sep 4:e70153. doi: 10.1111/nmo.70153.
    PubMed    
    Abstract available
    
    

20. MOSTAMAND S
    Median arcuate ligament syndrome: challenges, comorbidities, and controversies.
    Curr Opin Pediatr. 2025;37:447-451.
    PubMed    
    Abstract available
    
    

21. CHMELIR T, Jarkovska D, Pandey S, Chottova Dvorakova M, et al
    Neurogastroenterology: Current insights into gastrointestinal innervation in health and disease.
    Auton Neurosci. 2025;261:103339.
    PubMed    
    Abstract available
    
    

22. MASSIRONI S, Gallo C, Franchina M, Sbarigia C, et al
    Carcinoid syndrome mimicking irritable bowel syndrome: don't fall into the trap.
    Expert Rev Gastroenterol Hepatol. 2025 Sep 3. doi: 10.1080/17474124.2025.2557245
    PubMed    
    Abstract available
    
    

23. MIRGHANI HO
    Imaging findings of irritable bowel syndrome patients, and the diagnostic value of irritable bowel syndrome: A systematic review.
    World J Methodol. 2025;15:99785.
    PubMed    
    Abstract available
    
    

24. TIAN Q, Yu D, Shen J, Fang L, et al
    Wuling powder ameliorates diarrhea-predominant irritable bowel syndrome in mice by modulating gut mucosal microbiota and alleviating intestinal inflammation.
    Front Cell Infect Microbiol. 2025;15:1652186.
    PubMed    
    Abstract available
    
    

25. WANG D, Guo Y, Wu Z, Zhang H, et al
    Electroacupuncture at ST36 Alleviates Visceral Hypersensitivity and Anxiety via ACC-AIC Circuit Modulation in IBS Rats.
    Neuropsychiatr Dis Treat. 2025;21:1761-1781.
    PubMed    
    Abstract available
    
    

26. PANDIT SS, Meganathan P, Vedagiri H
    Harmonizing gut microbiota dysbiosis: Unveiling the influence of diet and lifestyle interventions.
    Metabol Open. 2025;27:100384.
    PubMed    
    Abstract available
    
    

27. LICHTENSTEIN GR
    Exploring Irritable Bowel Syndrome Symptoms in Patients With Inflammatory Bowel Disease.
    Gastroenterol Hepatol (N Y). 2025;21:407.
    PubMed    
    
    
    

28. GRACIE DJ, Ford AC
    Irritable Bowel Syndrome in Inflammatory Bowel Disease Patients: Prevalence, Etiology, and Treatment.
    Gastroenterol Hepatol (N Y). 2025;21:415-423.
    PubMed    
    Abstract available
    
    

29. YANG J, Li X, Wang C, Yang X, et al
    A Novel CHRM3-Driven Preclinical Model of Irritable Bowel Syndrome.
    FASEB J. 2025;39:e71015.
    PubMed    
    Abstract available
    
    

30. MAJURI M, Vuokko A, Korhonen M, Karvala K, et al
    Environmental exposure-related health worries, work ability and health, surveyed by occupational health services.
    Int J Occup Med Environ Health. 2025 Aug 29:208604.
    PubMed    
    Abstract available
    
    

31. MILLER VE, Barnhill J, Greco CM, Castro G, et al
    Prevalence of Chronic Overlapping Pain Conditions in Participants With Chronic Low Back Pain Enrolled in a Pragmatic Trial of Mindfulness-Based Stress Reduction.
    Eur J Pain. 2025;29:e70119.
    PubMed    
    Abstract available
    
    

32. VITA AA, Teo S, Murphy C, Khandaker AM, et al
    Safety, tolerability, and preliminary effects of cricket chitin for adults with IBS: a double-blind randomized crossover pilot trial.
    Food Funct. 2025 Sep 2. doi: 10.1039/d5fo01540.
    PubMed    
    Abstract available
    
    

33. LU YH, Lei SY, Yang T, Xu YS, et al
    PDE4 inhibitor apremilast ameliorates TNBS-induced irritable bowel syndrome in mice by activating the Nrf-2 signaling pathway in enteric glial cells.
    Acta Pharmacol Sin. 2025 Sep 1. doi: 10.1038/s41401-025-01649.
    PubMed    
    Abstract available
    
    

34. SUN MY, Xing HH, Lin X, Hong-haoWu, et al
    Electroacupuncture at Baliao Points Attenuates Visceral Hypersensitivity in Irritable Bowel Syndrome via Gut-Microbiota-Mast Cell-TPRV1 Axis Modulation.
    Neurogastroenterol Motil. 2025 Aug 31:e70137. doi: 10.1111/nmo.70137.
    PubMed    
    Abstract available
    
    

35. FOWLER S, Dowling LRC, Simm N, Talley NJ, et al
    Sleep Disturbances, Fatigue and Immune Markers in the Irritable Bowel Syndrome and Inflammatory Bowel Disease, a Systematic Review.
    Neurogastroenterol Motil. 2025 Aug 31:e70133. doi: 10.1111/nmo.70133.
    PubMed    
    Abstract available
    
    

36. SALARI-MOGHADDAM A, Feizi A, Hajihashemi P, Ani A, et al
    Adherence to EAT-Lancet diet and odds of irritable bowel syndrome and functional dyspepsia: the Isfahan functional disorders (ISFUN) study.
    Nutr J. 2025;24:134.
    PubMed    
    Abstract available
    
    

37. SALAGA M, Binienda A, Canale V, Grychowska K, et al
    Serotonin type 6 receptor inverse agonists and neutral antagonists inhibit defecation: relevance to intestinal motility disorders.
    Eur J Pharmacol. 2025;1005:178099.
    PubMed    
    Abstract available
    
    

38. MOROZOV SV, Pilipenko VI, Isakov VA, Sasunova AN, et al
    [The use of plant protein-based foods for the correction of dietary patterns in alimentary-dependent diseases: opportunities and prospects. A review].
    Ter Arkh. 2025;97:727-734.
    PubMed    
    Abstract available
    
    

39. YE J, Wu X, Liu J, Guo Y, et al
    An Effective Oral Drug Delivery Route for Pharmacokinetic Complications: Spirulina Lipid Nanotechnology System.
    Adv Sci (Weinh). 2025 Sep 12:e09731. doi: 10.1002/advs.202509731.
    PubMed    
    Abstract available
    
    

40. GORDON M, Groen J, Sinopoulou V, Chogle A, et al
    European and North American guidelines for treating irritable bowel syndrome and functional abdominal pain in childhood: a guide for health-care professionals.
    Lancet Child Adolesc Health. 2025 Sep 9:S2352-4642(25)00209.
    PubMed    
    Abstract available
    
    

41. MARASCO G, Barbara G, Bellini M, Portincasa P, et al
    Management of bile acid diarrhea in Italy: a survey.
    Intern Emerg Med. 2025 Sep 12. doi: 10.1007/s11739-025-04060.
    PubMed    
    Abstract available
    
    

42. KHAN U, Lied GA
    Wheat-Related Gastrointestinal Diseases: Narrative Review.
    Turk J Gastroenterol. 2025;36:540-546.
    PubMed    
    Abstract available
    
    

43. YAKLAI K, Kunasol C, Suparan K, Apaijai N, et al
    Electroacupuncture alleviates symptoms and identifies a potential microbial biomarker in patients with constipation-predominant irritable bowel syndrome.
    World J Gastrointest Pharmacol Ther. 2025;16:109046.
    PubMed    
    Abstract available
    
    

44. GARG A, Aldaoud N, Khan W, Kulairi ZI, et al
    Intraparenchymal Anaplastic Meningioma With Isolated Motor Deficits.
    Cureus. 2025;17:e89822.
    PubMed    
    Abstract available
    
    

45. GHUSN W, Gala K, Mrad R, Salame M, et al
    Disparities in the burden of gastrointestinal diseases: a comprehensive analysis of data from randomized clinical trials from 2000-2023.
    Ann Gastroenterol. 2025;38:488-496.
    PubMed    
    Abstract available
    
    

46. BENAMOUZIG R, El Arja W, Bejou B, Airinei G, et al
    Panenteric Capsule Endoscopy in Young Patients with Suspected Irritable Bowel Syndrome: A Self-Controlled Feasibility Study.
    Clin Exp Gastroenterol. 2025;18:205-213.
    PubMed    
    Abstract available
    
    

47. KIM YJ
    Therapeutic Potential of Melatonin in Functional Dyspepsia.
    Korean J Helicobacter Up Gastrointest Res. 2025;25:296-298.
    PubMed    
    Abstract available
    
    

48. WANG Q, Lu S, Yin Z
    Aloe-emodin Regulates Colon Epithelial Cell Function by Regulating HIF-1alpha to Alleviate Irritable Bowel Syndrome.
    Xenobiotica. 2025 Sep 11:1-16. doi: 10.1080/00498254.2025.2559959.
    PubMed    
    Abstract available
    
    

49. SATONAGA Y, Kudoh R, Hata M, Shigenaga T, et al
    Ramosetron as a Supportive Agent to Continue Nintedanib in Patients with Interstitial Lung Disease.
    Intern Med. 2025 Sep 11. doi: 10.2169/internalmedicine.5984.
    PubMed    
    Abstract available
    
    

50. JAIN W, Khaliq M, Wahab A, Laghari M, et al
    Evaluating Vitamin D Deficiency-Linked Digestive Issues by Bridging Endocrinology With Gastrointestinal Disorders.
    Cureus. 2025;17:e89598.
    PubMed    
    Abstract available
    
    

51. WARRAICH MUT, Shafqat MN, Ajmal U, Choudhary MA, et al
    Frequency of Celiac Disease in Irritable Bowel Syndrome: Insights From a Tertiary Care Hospital.
    Cureus. 2025;17:e89617.
    PubMed    
    Abstract available
    
    

52. ZHOU Y, Liu S, Zhang Q, Zhang S, et al
    Socioeconomic disparity and risk of irritable bowel syndrome: a cohort study with mediation analysis.
    Clin Gastroenterol Hepatol. 2025 Sep 7:S1542-3565(25)00754.
    PubMed    
    Abstract available
    
    

53. YUAN J, Pi C, Shen H, Zhou B, et al
    Potential therapeutic benefits of curcumin in depression or anxiety induced by chronic diseases: a systematic review of mechanistic and clinical evidence.
    Front Pharmacol. 2025;16:1638645.
    PubMed    
    Abstract available
    
    

54. BEZ P, Scapolan M, Ribaldone DG, Caviglia GP, et al
    Antibodies against integrin alphavbeta6 have high diagnostic accuracy for ulcerative colitis.
    Front Immunol. 2025;16:1641329.
    PubMed    
    Abstract available
    
    

55. HOYER KL, Kornum DS, Baunwall SMD, Klinge MW, et al
    Repeated faecal microbiota transplantation for individuals with type 1 diabetes and gastroenteropathy.
    Diabetologia. 2025 Sep 18. doi: 10.1007/s00125-025-06544.
    PubMed    
    Abstract available
    
    

56. YAN Q, Wang X, Jiang H, Zhou X, et al
    Decoding Barberry Root's Therapeutic Network: A Synergistic Solution for IBS-D.
    Comb Chem High Throughput Screen. 2025.
    PubMed    
    Abstract available
    
    

57. WANG Y, Pan T, Hu N, Gao G, et al
    The Role of Ganyu in Formation of Liver Depression and Spleen Deficiency Syndrome: Analysis From Gut Microbiota.
    Gastroenterol Res Pract. 2025;2025:2125189.
    PubMed    
    Abstract available
    
    

58. HAMMER J, Hammer HF
    Beyond Malabsorption: The Need for Symptom-Based Assessment in Suspected Lactose Intolerance. Lessons From a Test-Specific Symptom Assessment.
    Neurogastroenterol Motil. 2025 Sep 17:e70167. doi: 10.1111/nmo.70167.
    PubMed    
    Abstract available
    
    

59. BARLOW GM, Pimentel M
    Modern concepts of small intestinal bacterial overgrowth.
    Curr Opin Gastroenterol. 2025 Sep 18. doi: 10.1097/MOG.0000000000001135.
    PubMed    
    Abstract available
    
    

60. OLBERDING CR, Adili W, Herman M
    Eosinophilic Colitis in an Adult Patient: A Case Report.
    Cureus. 2025;17:e90099.
    PubMed    
    Abstract available
    
    

61. LI Y, Wang Z, Zhang S, Hua Y, et al
    miR-539-5p Regulates Irritable Bowel Syndrome Pathological Processes by Targeting KDM6A.
    Turk J Gastroenterol. 2025 Sep 10. doi: 10.5152/tjg.2025.24684.
    PubMed    
    Abstract available
    
    

62. QRMLI AA
    Modeling the Structural Relationships of Irritable Bowel Syndrome Symptom Severity Based on Hostile Attribution, Perceived Stress, and Cognitive Bias With the Mediating Role of Negative Meta-emotion.
    J Psychiatr Pract. 2025;31:245-250.
    PubMed    
    Abstract available
    
    

63. AL AYOUBI O, Aldakak MA, Alabdullah N, Alabdullah F, et al
    Sigmoid colon endometriosis as an uncommon cause of large bowel obstruction: A case report.
    Int J Surg Case Rep. 2025;135:111927.
    PubMed    
    Abstract available
    
    

64. DAHLGREN A, Gryback P, Jacobsson H, Hellstrom PM, et al
    Refined Lactulose Hydrogen Breath Test for Small Intestinal Bacterial Overgrowth Subgrouping Irritable Bowel Syndrome With Low and High Breath Hydrogen.
    Gastroenterol Res Pract. 2025;2025:5597071.
    PubMed    
    Abstract available
    
    

65. FAN Z, Yao J, Zeng X, Zuo J, et al
    Investigation of the biomarkers and mechanism based on endoplasmic reticulum stress in irritable bowel syndrome.
    Arab J Gastroenterol. 2025 Sep 22:S1687-1979(25)00110.
    PubMed    
    Abstract available
    
    

66. DRAGO L, Corleto VD, Ciprandi G, Brindicci VF, et al
    A multicenter real-world, open-label study assessing the impact of a probiotic mixture on symptoms of irritable bowel syndrome in adults.
    Benef Microbes. 2025 Sep 16:1-12. doi: 10.1163/18762891-bja00097.
    PubMed    
    Abstract available
    
    

67. SCOTT AJ, Correa AB, Bisby MA, Chandra SS, et al
    Cognitive Behavioral Therapy for Insomnia in People With Chronic Disease: A Systematic Review and Meta-Analysis.
    JAMA Intern Med. 2025 Sep 22:e254610. doi: 10.1001/jamainternmed.2025.4610.
    PubMed    
    Abstract available
    
    

68. WANG YL, Xu XQ, Long YY, Cheng YL, et al
    Characterization of gut microbiota and metabolites in individuals with constipation-predominant irritable bowel syndrome.
    Front Microbiol. 2025;16:1617288.
    PubMed    
    Abstract available
    
    

69. QU L, Zhang R, Chu Z, Cai J, et al
    Gut microbiota: A key player for soluble dietary fiber in regulating inflammatory disease.
    J Adv Res. 2025 Sep 17:S2090-1232(25)00732-5. doi: 10.1016/j.jare.2025.
    PubMed    
    Abstract available
    
    

70. GUEMES-GONZALEZ AM, Arriaga-Pizano LA, Chacon-Salinas R, Wong-Baeza I, et al
    Regulation of Intestinal Permeability in Health and Disease: Possible Therapeutic Applications.
    Arch Med Res. 2025;57:103321.
    PubMed    
    Abstract available
    
    

71. PARK CJ, Jones MP, Prott G, Sequeira C, et al
    Rome IV Functional Defecation Disorder: Time for a Change in Symptom Criteria for Improved Clinical Relevance?
    Am J Gastroenterol. 2024;120:2165-2172.
    PubMed    
    Abstract available
    
    

72. AHMED T, Lemberg DA, Day AS, Leach ST, et al
    The Interplay Between Immunological Status and Gut Microbial Dysbiosis in the Development of the Symptoms of Irritable Bowel Syndrome: A Systematic Review with Meta-Analysis.
    Dig Dis Sci. 2025 Sep 3. doi: 10.1007/s10620-025-09360.
    PubMed    
    Abstract available
    
    

73. NGUYEN DC, Gonlachanvit S, Sukaram T, Patcharatrakul T, et al
    Volatile Organic Compounds in Irritable Bowel Syndrome: Microbial Insights into Gut-Brain Dynamics and Clinical Applications.
    Digestion. 2025 Sep 4:1-14. doi: 10.1159/000548310.
    PubMed    
    Abstract available
    
    

74. ROKKAS T, Ekmektzoglou K, Tsanou E, Bricca L, et al
    Comparative effectiveness and safety of probiotics with psychotropic potential in mental health benefits in irritable bowel syndrome: a systematic review and network meta-analysis.
    Eur J Gastroenterol Hepatol. 2025 Aug 25. doi: 10.1097/MEG.0000000000003062.
    PubMed    
    Abstract available
    
    

75. FLACK R, Brownlow G, Burton-Murray H, Palsson O, et al
    The Prevalence and Burden of Avoidant/Restrictive Food Intake Disorder (ARFID) Symptoms in Adults with Disorders of Gut-Brain Interaction: A Population-Based Study.
    Gastroenterology. 2025 Aug 20:S0016-5085(25)05896.
    PubMed    
    Abstract available
    
    

76. ZAMFIR-TARANU A, Loscher BS, Franke A, Bonfiglio F, et al
    Sucrase-isomaltase hypomorphic variant Val15Phe affects the response to a sucrose challenge test in patients with IBS.
    Gut. 2025 Sep 10:gutjnl-2025-336393. doi: 10.1136/gutjnl-2025-336393.
    PubMed    
    
    
    

77. RAGHAVENDRAN AK, Musunuri B, Rajpurohit S, C GP, et al
    Evaluation of artificial intelligence-based patient education models for irritable bowel syndrome.
    Indian J Gastroenterol. 2025 Sep 20. doi: 10.1007/s12664-025-01872.
    PubMed    
    Abstract available
    
    

78. AHMED A, Chauhan A, Kumari A, Hokari R, et al
    Prevalence of Serologically Defined Celiac Disease in Patients With Irritable Bowel Syndrome in Asia: A Multicountry Hospital-Based Study.
    J Gastroenterol Hepatol. 2025 Sep 13. doi: 10.1111/jgh.70074.
    PubMed    
    Abstract available
    
    

79. LACH J, Colombo JM, Schurman JV, Friesen CA, et al
    Variability in stool symptoms in youth with abdominal pain-associated disorders of gut-brain interaction.
    J Pediatr Gastroenterol Nutr. 2025 Sep 1. doi: 10.1002/jpn3.70205.
    PubMed    
    Abstract available
    
    

80. BAI X, Guo X, Zhou Z, Liu S, et al
    Functional gastrointestinal disorders are highly prevalent in children with short stature and linked to reduced growth velocity.
    J Pediatr Gastroenterol Nutr. 2025 Sep 17. doi: 10.1002/jpn3.70203.
    PubMed    
    Abstract available
    
    

81. 
    Editorial Note: Somatization symptomology and its association with stress in patients with irritable bowel syndrome.
    PLoS One. 2025;20:e0331058.
    PubMed